Search

Your search keyword '"Palmisano, Lucia"' showing total 2 results
Start Over Author "Palmisano, Lucia" Topic highly active antiretroviral therapy Topic medical research
2 results on '"Palmisano, Lucia"'

1. Modifications of HIV-1 DNA and Provirus-Infected Cells During 24 Months of Intermittent Highly Active Antiretroviral Therapy.

Author

Palmisano, Lucia, Giuliano, Marina, Chiarotti, Flavia, Zanchetta, Marisa, Andreotti, Mauro, Pirillo, Maria F., Riva, Elisabetta, Antonelli, Guido, De Rossi, Anita, and Vella, Stefano

Subjects
*DNA, *HIV, *HIV infections, *CELLS, *CLINICAL trials, *POLYMERASE chain reaction, *BLOOD, *MEDICAL research
Abstract

The article presents a study on cell-associated HIV-1 DNA and provirus-infected cells during the Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) clinical trial. It states that HIV-1 DNA was calculated by a real-time polymerase chain reaction (PCR) in the peripheral blood mononuclear cells (PBMCs) of 37 subjects enrolled in the ISS-PART.

Published
2008
Full Text
View/download PDF

2. Determinants of Virologic and Immunologic Outcomes in Chronically HIV-Infected Subjects Undergoing Repeated Treatment Interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) Study.

Author

Palmisano, Lucia, Giuliano, Marina, Bucciardini, Raffaella, Fragola, Vincenzo, Andreotti, Mauro, Galluzzo, Clementina M., Pirillo, Maria F., Weimer, Liliana E., Arcieri, Romano, Germinario, Elena A. P., Amici, Roberta, Mancini, Maria Grazia, d'Arminio Monforte, Antonella, Castelli, Francesco, Caramello, Pietro, and Vella, Stefano

Subjects
*HIV infections, *HIGHLY active antiretroviral therapy, *ANTIVIRAL agents, *HIV, *RANDOMIZED controlled trials, *IMMUNE system, *MEDICAL research
Abstract

The article presents a randomized study which determines the factors that influence the virologic and immunologic outcome of structured interruptions (STIs) in HIV chronic infection. The main outcome measures of the study was aimed at testing the noninferiority of STIs to continuous highly active antiretroviral therapy (HAART) in terms of CD4 cell count. The results of the study is presented and discussed.

Published
2007
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results